Article

Lumenis unveils retinal laser delivery technology

Lumenis Ltd. introduced an ophthalmic laser delivery technology and slit lamp biomicroscope system (InSight) at the recent annual meeting of the American Academy of Ophthalmology.

San Francisco

-Lumenis Ltd. introduced an ophthalmic laser delivery technology and slit lamp biomicroscope system (InSight) at the recent annual meeting of the American Academy of Ophthalmology.

The system “successfully addresses some of the well-known challenges in ophthalmic laser delivery devices, namely, clear visualization of the retina and precise laser delivery to the target tissue,” said Dov Ofer, president and chief executive officer, Lumenis.

The device is designed to allow customizable treatments through a proprietary co-linear optical design mechanism (CoLin) that projects the illumination and laser beam through the same pathway, according to Lloyd Diamond, vice president and general manager of Lumenis Vision, the ophthalmic business unit of Lumenis. A joystick controls the co-linear optical mechanism, and the device also includes patented technology (AcuGuide) to address fine movement and beam manipulation.

Pazit Pianka, MD, medical director, Lumenis Vision, said, “Whether you are performing pan-retinal photocoagulation or a macular focal or grid laser treatment, the [system] provides you with complete control throughout the procedure, making the procedure easier for the treating physician.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
© 2025 MJH Life Sciences

All rights reserved.